# K033813: Micrus Modified Microcoil System, Cerecyte

- Pathway: 510(k) (Traditional)
- Applicant: Micrus Corp.
- Decided: Feb 4, 2004 after 57 days
- Product code: HCG (Device, Neurovascular Embolization)
- Device class: 2
- Regulation: 21 CFR 882.5950
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 6 generations back to K951256 (1995). 26 ancestors in all.
40 later devices descend from it; 4 cite it directly.
1 of 67 devices in its family (counting itself) has a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K022420: Micrus Stretch-Resistant Microcoil System, MSR01, Micrus Corp. (2002) Summary page 1.
- K002056: Micrus Microcoil Delivery System, MDS03, Micrus Corp. (2001) Summary page 1.

## Most influential descendants
- K053160: Micrus Modified Microcoil 18-System, Cerecyte, Model CSP & Che (2005), 35 descendants of its own
- K062036: Micrus Microcoil System Presidio-18, Model PC4 (2006), 34 descendants of its own
- K070707: Micrus Microcoil System (2007), 32 descendants of its own
- K073442: Micrus Microcoil Systems (2008), 31 descendants of its own
- K081465: Axium Detachable Coil System (2008), 22 descendants of its own

## Indications for use
The Micrus MicroCoil Delivery System is intended for endovascular embolization of intracranial aneurysms.

Source page: https://510kreport.com/device/K033813
Methodology: https://510kreport.com/methodology